| scholarly article | Q13442814 |
| P50 | author | Albert de la Chapelle | Q5618748 |
| Riccardo Fodde | Q40691036 | ||
| P2093 | author name string | C Richard Boland | |
| Henry T Lynch | |||
| Gordon Gong | |||
| Jane F Lynch | |||
| Patrick M Lynch | |||
| Trudy G Shaw | |||
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
| Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X | Q24618839 | ||
| Genetic mapping of a locus predisposing to human colorectal cancer | Q28268634 | ||
| Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
| Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis colorectal cancer | Q33188288 | ||
| Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome. | Q33676566 | ||
| Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene | Q33904639 | ||
| Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer | Q33930691 | ||
| The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population | Q34161196 | ||
| Founding mutations and Alu-mediated recombination in hereditary colon cancer | Q34297390 | ||
| Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. | Q34414061 | ||
| Somatic acquisition and signaling of TGFBR1*6A in cancer | Q34456847 | ||
| Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). | Q34557362 | ||
| Genetic testing for inherited colon cancer | Q34557532 | ||
| Lack of benefit of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer with microsatellite instability | Q35025942 | ||
| Recurrent germline mutation in MSH2 arises frequently de novo | Q35435822 | ||
| The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC) | Q35447160 | ||
| Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation | Q35594413 | ||
| Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors | Q35748966 | ||
| Genetic predisposition to colorectal cancer | Q35930688 | ||
| Colon cancer screening in 2005: status and challenges | Q36123825 | ||
| Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine | Q37357197 | ||
| Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage | Q38320078 | ||
| Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques | Q38351153 | ||
| Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer | Q38449001 | ||
| Colorectal adenoma progression and genetic change: is there a link? | Q40405126 | ||
| Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. | Q40582817 | ||
| Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status | Q40706999 | ||
| Mammalian cells defective in DNA mismatch correction | Q40707499 | ||
| Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer | Q40918327 | ||
| Hypermutability and mismatch repair deficiency in RER+ tumor cells | Q41508298 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| American founder mutation for Lynch syndrome. Prevalence estimates and implications | Q43563170 | ||
| Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. | Q44763095 | ||
| Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). | Q45185739 | ||
| Family information service and hereditary cancer | Q46153942 | ||
| TGFBR1*6A may contribute to hereditary colorectal cancer | Q46463202 | ||
| A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States | Q46655105 | ||
| Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome | Q47604676 | ||
| Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer | Q50854368 | ||
| Hereditary proximal colonic cancer | Q50945054 | ||
| Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC | Q54559294 | ||
| p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. | Q54702629 | ||
| New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. | Q55033068 | ||
| Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer | Q57200562 | ||
| p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome | Q57567770 | ||
| Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer | Q57567891 | ||
| Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease | Q57567959 | ||
| Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation | Q57735554 | ||
| A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines | Q57978042 | ||
| Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource | Q62772420 | ||
| Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies | Q62772424 | ||
| A 10-Mb paracentric inversion of chromosome arm 2p inactivatesMSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred | Q62977759 | ||
| Progress in Genetic Testing, Classification, and Identification of Lynch Syndrome | Q62978207 | ||
| Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) | Q62978356 | ||
| The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) | Q62978412 | ||
| Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. | Q64964658 | ||
| Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? | Q71000854 | ||
| Hereditary colorectal cancer | Q73088287 | ||
| Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer | Q73345126 | ||
| Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum | Q73792103 | ||
| Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma | Q74046178 | ||
| Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors | Q77639637 | ||
| Microsatellite alterations in various sarcomas in Japanese patients | Q77885941 | ||
| Re: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q80563869 | ||
| The family history--more important than ever | Q81059123 | ||
| Molecular screening for the Lynch syndrome--better than family history? | Q81716567 | ||
| P433 | issue | 4 | |
| P921 | main subject | Lynch syndrome | Q783644 |
| management implication | Q122759851 | ||
| P304 | page(s) | 390-402 | |
| P577 | publication date | 2006-04-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | European Journal of Human Genetics | Q2155433 |
| P1476 | title | Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications | |
| P478 | volume | 14 |
| Q37693398 | A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers |
| Q57200486 | A database to support the interpretation of human mismatch repair gene variants |
| Q35560811 | Anticipation in Lynch Syndrome: Where We Are Where We Go |
| Q35223852 | Bayesian modeling for genetic anticipation in presence of mutational heterogeneity: a case study in Lynch syndrome |
| Q35799369 | Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome |
| Q34174654 | Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC). |
| Q62122325 | Co-occurrence of nonsense mutations in MSH6 and MSH2 in Lynch syndrome families evidencing that not all truncating mutations are equal |
| Q35269096 | Colorectal cancers with microsatellite instability display unique miRNA profiles. |
| Q34243496 | Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes |
| Q91895870 | Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China |
| Q36315747 | Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer |
| Q34610509 | Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model |
| Q33797266 | Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome |
| Q36951321 | Familial and genetic risk of transitional cell carcinoma of the urinary tract |
| Q92610418 | Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients |
| Q53797307 | Gastrointestinal oncology: the genetics of colorectal cancer |
| Q37073895 | Genetic predispositions to childhood leukemia. |
| Q37468316 | Genetic risk and gynecologic cancers. |
| Q36422099 | Genetic testing for Lynch syndrome: family communication and motivation |
| Q37566958 | Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome |
| Q50483935 | Genetics of colorectal cancer |
| Q38679590 | Haematuria in association with Lynch syndrome |
| Q36768291 | Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control |
| Q34713100 | Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. |
| Q38153188 | Hereditary ovarian and breast cancer: what have we learned? |
| Q34480707 | Hereditary ovarian cancer: not only BRCA 1 and 2 genes. |
| Q34977063 | Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management |
| Q36784319 | Hereditary urological cancer syndromes |
| Q37206009 | Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome |
| Q36734614 | Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing |
| Q35233167 | Lynch syndrome: barriers to and facilitators of screening and disease management |
| Q33933576 | MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. |
| Q93161798 | Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation |
| Q38741029 | Mismatch repair deficiency testing in clinical practice |
| Q37696965 | Mismatch repair deficient colorectal cancer in the era of personalized treatment |
| Q86707419 | Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese lynch syndrome families |
| Q33862772 | Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico |
| Q56986492 | Molecular and presymptomatic analysis of a Moroccan Lynch syndrome family revealed a novel frameshift MLH1 germline mutation |
| Q91782154 | Ovarian metastases from ileum cancer in a patient with germline EPCAM gene deletion successfully treated with surgical resection and CAPOX chemotherapy: a case report |
| Q36847930 | Pathology of the hereditary colorectal carcinoma |
| Q36826190 | Pediatric adenomatous polyposis syndromes: an update |
| Q36094483 | Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases |
| Q42836059 | Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. |
| Q35168638 | Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome |
| Q48282014 | Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population |
| Q42175718 | Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer |
| Q81524412 | Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome |
| Q34613862 | Recording of family history is associated with colorectal cancer stage |
| Q24610838 | Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications |
| Q34163849 | Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma |
| Q37712344 | Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study. |
| Q51772302 | Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation |
| Q37221791 | Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis |
| Q34961305 | Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry. |
| Q41894902 | Synchronous rectal and gastric cancer in a fighter pilot: aeromedical concerns |
| Q42638396 | The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation |
| Q36923700 | The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy |
| Q39818303 | Unstable DNA repair genes shaped by their own sequence modifying phenotypes. |
| Q36890349 | Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients |
| Q87388061 | [Genetics of colorectal cancer] |
Search more.